Douglas W. Olms

Array ( [id] => 16954203 [patent_doc_number] => RE048636 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-07-13 [patent_title] => Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban [patent_app_type] => reissue [patent_app_number] => 16/662518 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9429 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17285862 [patent_doc_number] => RE048856 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-12-21 [patent_title] => Inhibition of NEAT1 for treatment of solid tumors [patent_app_type] => reissue [patent_app_number] => 16/598873 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 38 [patent_no_of_words] => 10204 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18273172 [patent_doc_number] => RE049477 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-03-28 [patent_title] => Engineered antibody for inhibition of fibrosis [patent_app_type] => reissue [patent_app_number] => 16/590929 [patent_app_country] => US [patent_app_date] => 2019-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 12033 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16590929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17328704 [patent_doc_number] => RE048887 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-01-11 [patent_title] => RNA interference compositions and methods for malignant tumors [patent_app_type] => reissue [patent_app_number] => 16/576102 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23217 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16997738 [patent_doc_number] => RE048665 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-08-03 [patent_title] => Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde [patent_app_type] => reissue [patent_app_number] => 16/548790 [patent_app_country] => US [patent_app_date] => 2019-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11196 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17602282 [patent_doc_number] => RE049076 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-05-17 [patent_title] => Compositions and methods for treating renal disease [patent_app_type] => reissue [patent_app_number] => 16/519648 [patent_app_country] => US [patent_app_date] => 2019-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22631 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17725880 [patent_doc_number] => RE049129 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-07-12 [patent_title] => Method of treatment of hypoxia inducible factor (HIF)-related conditions [patent_app_type] => reissue [patent_app_number] => 16/455104 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 5215 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17820930 [patent_doc_number] => RE049192 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-08-30 [patent_title] => Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile [patent_app_type] => reissue [patent_app_number] => 16/427106 [patent_app_country] => US [patent_app_date] => 2019-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 19880 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16680144 [patent_doc_number] => RE048461 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-03-09 [patent_title] => Modulation of androgen receptor expression [patent_app_type] => reissue [patent_app_number] => 16/275198 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58582 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16923381 [patent_doc_number] => RE048608 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-06-29 [patent_title] => Method to predict response to pharmacological chaperone treatment of diseases [patent_app_type] => reissue [patent_app_number] => 16/222305 [patent_app_country] => US [patent_app_date] => 2018-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 23 [patent_no_of_words] => 13116 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15570169 [patent_doc_number] => RE047885 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-03-03 [patent_title] => Use of cannabidiol prodrugs in pharmaceutical compositions [patent_app_type] => reissue [patent_app_number] => 16/219285 [patent_app_country] => US [patent_app_date] => 2018-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21700 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17118205 [patent_doc_number] => RE048751 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-09-28 [patent_title] => Immunoconjugates with an intracellularly-cleavable linkage [patent_app_type] => reissue [patent_app_number] => 16/218384 [patent_app_country] => US [patent_app_date] => 2018-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24898 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17711671 [patent_doc_number] => RE049121 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-07-05 [patent_title] => Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formation [patent_app_type] => reissue [patent_app_number] => 16/190053 [patent_app_country] => US [patent_app_date] => 2018-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5644 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16531464 [patent_doc_number] => RE048370 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-12-29 [patent_title] => Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus [patent_app_type] => reissue [patent_app_number] => 16/152031 [patent_app_country] => US [patent_app_date] => 2018-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19395 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152031 [rel_patent_id] =>[rel_patent_doc_number] =>)